MSL
HAE icon

Mackay Shields LLC’s Haemonetics HAE Stock Holding History

Mackay Shields LLC’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,400
Closed -$2.27M – 1473
2020
Q2 		$2.27M Sell
25,400
-9,800
-28% -$990K 0.02% 693
2020
Q1 		$3.51M Sell
35,200
-7,000
-17% -$759K 0.03% 460
2019
Q4 		$4.85M Buy
42,200
+9,400
+29% +$1.14M 0.03% 470
2019
Q3 		$4.14M Buy
+32,800
New +$4.16M 0.03% 583
2019
Q2 		– Sell
-18,705
Closed -$1.64M – 1444
2019
Q1 		$1.64M Sell
18,705
-5,900
-24% -$537K 0.01% 785
2018
Q4 		$2.46M Sell
24,605
-48,837
-66% -$5.13M 0.02% 621
2018
Q3 		$8.41M Sell
73,442
-8,556
-10% -$886K 0.06% 343
2018
Q2 		$7.35M Buy
81,998
+17,198
+27% +$1.45M 0.05% 404
2018
Q1 		$4.74M Buy
+64,800
New +$4.45M 0.03% 512

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackay Shields LLC's HAE Position: Q3 2020 in Review

Mackay Shields LLC sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 25,400 shares — an estimated $2.27M sold.

Mackay Shields LLC first reported a position in HAE in Q1 2018 and held it in 9 quarters. The position peaked at $8.41M in Q3 2018. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • Mackay Shields LLC reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 25,400 Haemonetics shares in Q3 2020, an estimated $2.27M.
  • Mackay Shields LLC first reported a position in Haemonetics in Q1 2018 and held it in 9 quarters.
  • Mackay Shields LLC's Haemonetics position peaked at $8.41M in Q3 2018.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.